Market Recap: Monday, October 5

Stocks rose Monday, recovering after Friday’s losses as market participants continued to closely monitor developments around President Donald Trump’s health. Shares of Regeneron Pharmaceuticals gained more than 7% intraday, with Trump having received the company’s experimental antibody drug as part of his treatment.